Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Al-Azhar Medical Journal. 1999; 28 (3-4): 333-340
Dans Anglais | IMEMR | ID: emr-50146

Résumé

The lateralized pattern of somatic symptoms is controversial and most Western and Far East studies detected more symptoms on the left side of the body, especially pain. Additional studies are needed to determine left or right predominance of psychogenic somatic symptoms. Seventy-six right handed Arab Muslim patients with depressive disorders, anxiety disorder and somatization disorder were examined for the lateralized distribution of somatic symptoms in their body and its relationship to diagnosis. Somatic symptoms were presented more on the left side than the right side. There was no significant difference between right sided and left sided group in sociodemographic variables, such as age, gender, marital status and education. Chest and upper limb pain were significantly more on the left side, while neurological symptoms [weakness and numbness] were more significant on the right side. The results revealed that somatization is not a simply lateralized, but reflects a complex interaction of many factors and culture plays a major role in determining the lateralized pattern


Sujets)
Humains , Mâle , Femelle , Islam , Trouble dépressif , Environnement social , Latéralité fonctionnelle , Culture (sociologie) , Arabes
2.
Al-Azhar Medical Journal. 1999; 28 (3-4): 425-438
Dans Anglais | IMEMR | ID: emr-50155

Résumé

Sixty-four patients with generalized social phobia were randomly assigned to Moclobemide, Paroxetine and cognitive behavior therapy groups for twelve weeks. The pattern of response was assessed. Response rate was 47.8, 50 and 23.4% for Moclobemide, Paroxetine and cognitive behavior therapy groups, respectively. Moclobemide was superior in reducing the somatic symptoms and interpersonal sensitivity. Paroxetine was superior in reducing global anxiety symptoms and obsessive compulsive symptoms. Both groups were superior to cognitive behavior therapy in reducing avoidance behavior. Cognitive behavior therapy was superior to Paroxetine in reducing interpersonal sensitivity


Sujets)
Humains , Mâle , Femelle , Troubles phobiques/thérapie , Moclobémide , Paroxétine , Thérapie comportementale , Résultat thérapeutique
SÉLECTION CITATIONS
Détails de la recherche